Safety and Tolerability of Monoclonal Antibody Therapies for Treatment of COVID-19 in Pediatric Patients.
Pediatr Infect Dis J
; 40(12): e507-e509, 2021 12 01.
Article
in English
| MEDLINE | ID: covidwho-1625475
ABSTRACT
There is a little data regarding safety or efficacy of monoclonal antibody treatment for mild-to-moderate COVID-19 in pediatric patients despite it being frequently used in adults. This retrospective study of 17 patients with mild-to-moderate COVID-19 who received monoclonal antibody therapy found that the treatment was well tolerated, safe, and may be effective in halting progression to severe disease.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antibodies, Neutralizing
/
Antibodies, Monoclonal, Humanized
/
SARS-CoV-2
/
COVID-19
/
Antibodies, Monoclonal
Type of study:
Observational study
Limits:
Adolescent
/
Adult
/
Child
/
Humans
/
Young adult
Language:
English
Journal:
Pediatr Infect Dis J
Journal subject:
Communicable Diseases
/
Pediatrics
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS